A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients

Clinical trial NCT04612413 · COMPLETED

Trial details

NCT number: NCT04612413
Sponsor: Enlivex Therapeutics Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis Community-acquired Pneumonia Urinary Tract Infections Cholecystitis, Acute Cholangitis Acute Intraabdominal Infections

Start date: 2020-11-30
Primary completion: 2024-01-12
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.